- Presentations
- 7
- Markets
- 1
Otrexup is a brand of Methotrexate marketed by Antares Pharma, with 7 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Methotrexate
- Brand owner
- Antares Pharma
- Registered in
- United States
- Strengths and forms
- 10 mg/0.4 mL injection, 12.5 mg/0.4 mL injection, 15 mg/0.4 mL injection, 17.5 mg/0.4 mL injection, 20 mg/0.4 mL injection, 22.5 mg/0.4 mL injection, 25 mg/0.4 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Otrexup 10 mg/0.4 mL injectionSubcutaneous | Antares Pharma | US FDA | Available on request |
| Otrexup 12.5 mg/0.4 mL injectionSubcutaneous | Antares Pharma | US FDA | Available on request |
| Otrexup 15 mg/0.4 mL injectionSubcutaneous | Antares Pharma | US FDA | Available on request |
| Otrexup 17.5 mg/0.4 mL injectionSubcutaneous | Antares Pharma | US FDA | Available on request |
| Otrexup 20 mg/0.4 mL injectionSubcutaneous | Antares Pharma | US FDA | Available on request |
| Otrexup 22.5 mg/0.4 mL injectionSubcutaneous | Antares Pharma | US FDA | Available on request |
| Otrexup 25 mg/0.4 mL injectionSubcutaneous | Antares Pharma | US FDA | Available on request |
Equivalent brands
Other brands of Methotrexate.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Otrexup
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.